LENFA Biotech Corp Sdn Bhd, a traditional Chinese medicine (TCM) manufacturer, aims to list on the Mesdaq market by the end of next year.
Chairman Wee Ah Yoong said part of the listing proceeds would be used to finance the company's proposed plant in China.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!